Pharmacology Research and Perspectives

SJR Rank #7,662H-index: 53SJR: 0.742Best quartile: Q1Open AccessAPC: US$4,160Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Wiley-Blackwell Publishing Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • NeurologyQ2

Areas: Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Receptor Mechanisms and SignalingPharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsNeuroscience and Neuropharmacology ResearchAntibiotics Pharmacokinetics and EfficacyNeuropeptides and Animal PhysiologyCholinesterase and Neurodegenerative DiseasesPharmaceutical Practices and Patient OutcomesPharmacological Effects and Toxicity StudiesPharmacovigilance and Adverse Drug Reactions

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs095190285380

Documents per Year

2022202504080120160

Detailed Information

ISSN

2052-1707

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.48

References per Document

45.61

Coverage

2013-2026

Scope

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

Metrics from SCImago Journal Rank 2025. View on SCImago